Evidence map›Paper›PMID 36586075›Full record

ArticlePharmacological reports : PR2023

Molecular pattern of a decrease in the rewarding effect of cocaine after an escalating-dose drug regimen.

Karolina Kołosowska, Małgorzata Lehner, Anna Skórzewska, Aleksandra Gawryluk, Filip Tomczuk, Alicja Sobolewska, Danuta Turzyńska, Monika Liguz-Lęcznar, Małgorzata Bednarska-Makaruk, Piotr Maciejak and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Pharmacological reports : PR, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Karolina KołosowskaDepartment of Neurochemistry, Institute of Psychiatry and Neurology, 9 Sobieskiego Street, 02-957, Warsaw, Poland. kkolosowska@ipin.edu.pl.
Małgorzata LehnerDepartment of Neurochemistry, Institute of Psychiatry and Neurology, 9 Sobieskiego Street, 02-957, Warsaw, Poland.
Anna SkórzewskaDepartment of Neurochemistry, Institute of Psychiatry and Neurology, 9 Sobieskiego Street, 02-957, Warsaw, Poland.
Aleksandra GawrylukDepartment of Molecular and Cellular Neurobiology, Nencki Institute of Experimental Biology, Polish Academy of Sciences, 3 Pasteur Street, 02-093, Warsaw, Poland.
Filip TomczukDepartment of Genetics, Institute of Psychiatry and Neurology, 9 Sobieskiego Street, 02-957, Warsaw, Poland.
Alicja SobolewskaDepartment of Neurochemistry, Institute of Psychiatry and Neurology, 9 Sobieskiego Street, 02-957, Warsaw, Poland.
Danuta TurzyńskaDepartment of Neurochemistry, Institute of Psychiatry and Neurology, 9 Sobieskiego Street, 02-957, Warsaw, Poland.
Monika Liguz-LęcznarDepartment of Molecular and Cellular Neurobiology, Nencki Institute of Experimental Biology, Polish Academy of Sciences, 3 Pasteur Street, 02-093, Warsaw, Poland.
Małgorzata Bednarska-MakarukDepartment of Genetics, Institute of Psychiatry and Neurology, 9 Sobieskiego Street, 02-957, Warsaw, Poland.
Piotr MaciejakDepartment of Neurochemistry, Institute of Psychiatry and Neurology, 9 Sobieskiego Street, 02-957, Warsaw, Poland.
Aleksandra Wisłowska-StanekDepartment of Experimental and Clinical Pharmacology, Medical University of Warsaw, Centre for Preclinical Research and Technology (CePT), 1B Banacha Street, 02-097, Warsaw, Poland.
Institute of Psychiatry and Neurology · PLInstytut Biologii Doświadczalnej im. Marcelego Nenckiego · PLMedical University of Warsaw · PLPolish Academy of Sciences · PL

Funding

Institute of Psychiatry and Neurology, Warsaw 501-40003-18017Narodowe Centrum Nauki 2018/28/C/NZ7/00240
6 · The paper itself

Abstract

backgroundLong-term cocaine exposure leads to dysregulation of the reward system and initiates processes that ultimately weaken its rewarding effects. Here, we studied the influence of an escalating-dose cocaine regimen on drug-associated appetitive behavior after a withdrawal period, along with corresponding molecular changes in plasma and the prefrontal cortex (PFC).

methodsWe applied a 5 day escalating-dose cocaine regimen in rats. We assessed anxiety-like behavior at the beginning of the withdrawal period in the elevated plus maze (EPM) test. The reinforcement properties of cocaine were evaluated in the Conditioned Place Preference (CPP) test along with ultrasonic vocalization (USV) in the appetitive range in a drug-associated context. We assessed corticosterone, proopiomelanocortin (POMC), β-endorphin, CART 55-102 levels in plasma (by ELISA), along with mRNA levels for D2 dopaminergic receptor (D2R), κ-receptor (KOR), orexin 1 receptor (OX1R), CART 55-102, and potential markers of cocaine abuse: miRNA-124 and miRNA-137 levels in the PFC (by PCR).

resultsRats subjected to the escalating-dose cocaine binge regimen spent less time in the cocaine-paired compartment, and presented a lower number of appetitive USV episodes. These changes were accompanied by a decrease in corticosterone and CART levels, an increase in POMC and β-endorphin levels in plasma, and an increase in the mRNA for D2R and miRNA-124 levels, but a decrease in the mRNA levels for KOR, OX1R, and CART 55-102 in the PFC.

conclusionsThe presented data reflect a part of a bigger picture of a multilevel interplay between neurotransmitter systems and neuromodulators underlying processes associated with cocaine abuse.

Indexed as

CocaineCocaine-Related DisordersMicroRNAsAnimalsbeta-EndorphinCorticosteronePro-OpiomelanocortinRatsRewardRNA, Messengerbeta-EndorphinCocaineCorticosteroneMicroRNAsMIRN124 microRNA, ratPro-OpiomelanocortinRNA, MessengerCocaine bingeHPA axisKORmicroRNANeuromodulatorsOX1R

Identifiers

PMID36586075
PMCPMC9889529
OpenAlexW4313324979

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.